Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Y. Pan"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 48
Tytuł:
Exploration and machine learning model development for T2 NSCLC with bronchus infiltration and obstructive pneumonia/atelectasis.
Autorzy:
Jin X; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Pan Y; Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
Zhai C; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Shen H; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
You L; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China. .
Pan H; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 27; Vol. 14 (1), pp. 4793. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Pulmonary Atelectasis*/pathology
Pneumonia*/pathology
Humans ; Neoplasm Staging ; Prognosis ; Bronchi/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Whole‑exome sequencing reveals Lewis lung carcinoma is a hypermutated Kras/Nras-mutant cancer with extensive regional mutation clusters in its genome.
Autorzy:
He Q; Department of Chemistry, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Sun C; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, China. .
Pan Y; Department of Chemistry, Zhejiang University, Hangzhou, 310058, Zhejiang, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 02; Vol. 14 (1), pp. 100. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Carcinoma, Lewis Lung*
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Male ; Humans ; Mice ; Animals ; Exome Sequencing ; Mice, Inbred C57BL ; Mutation ; Proto-Oncogene Proteins p21(ras)/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
FOXA1-induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF-β signaling pathway.
Autorzy:
Wei J; Department of Tumor Chemotherapy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Yu H; Department of Tumor Chemotherapy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Liu T; Department of Medical Oncology, 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei, China.
Wang Z; Department of Tumor Chemotherapy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Lang C; Department of Orthopedics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Pan Y; Department of Tumor Chemotherapy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Jul; Vol. 14 (21), pp. 2026-2037. Date of Electronic Publication: 2023 Jun 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
MicroRNAs*/genetics
MicroRNAs*/metabolism
Lung Neoplasms*/pathology
Adenocarcinoma*/genetics
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Humans ; Animals ; Mice ; Receptor, Transforming Growth Factor-beta Type I/genetics ; Receptor, Transforming Growth Factor-beta Type I/metabolism ; Cell Line, Tumor ; Cell Proliferation/genetics ; Cell Movement/genetics ; Lung/pathology ; Carcinogenesis/genetics ; Cell Transformation, Neoplastic/genetics ; Signal Transduction ; Transforming Growth Factor beta/genetics ; Transforming Growth Factor beta/metabolism ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HRG inhibits liver cancer lung metastasis by suppressing neutrophil extracellular trap formation.
Autorzy:
Yin Y; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai, China.; Shanghai Institute of Transplantation, Shanghai, China.
Dai H; Department of Breast Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Sun X; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai, China.; Shanghai Institute of Transplantation, Shanghai, China.
Xi Z; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai, China.; Shanghai Institute of Transplantation, Shanghai, China.
Zhang J; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai, China.; Shanghai Institute of Transplantation, Shanghai, China.
Pan Y; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai, China.; Shanghai Institute of Transplantation, Shanghai, China.
Huang Y; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai, China.; Shanghai Institute of Transplantation, Shanghai, China.
Ma X; Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China.
Xia Q; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai, China.; Shanghai Institute of Transplantation, Shanghai, China.
He K; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai, China.; Shanghai Institute of Transplantation, Shanghai, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Jun; Vol. 13 (6), pp. e1283.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Extracellular Traps*/metabolism
Liver Neoplasms*/metabolism
Liver Neoplasms*/pathology
Lung Neoplasms*/metabolism
Lung Neoplasms*/secondary
Animals ; Mice ; NF-kappa B/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Emerging evidence and treatment paradigm of non-small cell lung cancer.
Autorzy:
Liu SM; Department of Hematology, The First Affiliated Hospital, Jinan University, Guangzhou, 510632, China.
Zheng MM; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Pan Y; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Liu SY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Li Y; Department of Hematology, The First Affiliated Hospital, Jinan University, Guangzhou, 510632, China. .; Institute of Hematology, School of Medicine, Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, China. .
Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan Er Road, Guangzhou, 510080, China. .; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2023 Apr 17; Vol. 16 (1), pp. 40. Date of Electronic Publication: 2023 Apr 17.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Humans ; Immunotherapy/methods ; Programmed Cell Death 1 Receptor ; B7-H1 Antigen
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in EGFR-mutated non-small cell lung cancer: A real-world study.
Autorzy:
Hu C; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wu S; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.; Department of Internal Medicine Oncology, The First Affiliated Hospital of University of South China, Hengyang, Hunan Province, China.
Deng R; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.; Department of Oncology, ZhuZhou Second Hospital, ZhuZhou, Hunan, China.
Wu Y; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Pan Y; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Shu L; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.; Hunan Cancer Mega-Data Intelligent Application and Engineering Research Centre, Changsha, Hunan, China.; Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.; Hunan Key Laboratory of Early Diagnosis and Precision Therapy in Lung Cancer, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (1), pp. 266-273. Date of Electronic Publication: 2022 Jun 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; ErbB Receptors/genetics ; Protein Kinase Inhibitors/adverse effects ; Retrospective Studies ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pyrimidinergic receptor P2Y6 expression is elevated in lung adenocarcinoma and is associated with poor prognosis.
Autorzy:
Wang X; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Zhao B; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Ren D; Department of Pathology, Daqing Longnan Hospital, Daqing, Heilongjiang, China.; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Hu X; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Qiao J; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Zhang D; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Zhang Y; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Pan Y; Department of Anatomy, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Fan Y; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Liu L; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Wang X; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Ma H; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Jia X; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Song S; Department of Histology and Embryology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Zhao C; Library of Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Liu J; Department of Pathology, Daqing Longnan Hospital, Daqing, Heilongjiang, China.
Wang L; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Pokaż więcej
Źródło:
Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2023; Vol. 38 (2), pp. 191-201.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/pathology
Humans ; Lung/pathology ; Prognosis ; RNA, Messenger/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Research Trends around Exercise Rehabilitation among Cancer Patients: A Bibliometrics and Visualized Knowledge Graph Analysis.
Autorzy:
Pan Y; Department of General Surgery, Tenth People's Hospital of Tongji University, Tongji University School of Medicine, Shanghai 200072, China.
Deng X; Department of Neurosurgery, Tenth People's Hospital of Tongji University, Tongji University School of Medicine, Shanghai 200072, China.
Zhuang Y; Colorectal Cancer Center, Shanghai Tenth People's Hospital, Shanghai 200072, China.
Li J; Department of General Surgery, Tenth People's Hospital of Tongji University, Tongji University School of Medicine, Shanghai 200072, China.; Geriatric Cancer Center, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2022 May 27; Vol. 2022, pp. 3755460. Date of Electronic Publication: 2022 May 27 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
Lung Neoplasms*
Activities of Daily Living ; Bibliometrics ; Fatigue ; Humans ; Pattern Recognition, Automated ; Quality of Life ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
Autorzy:
Yang H; Department of Oncology, Shanghai Pulmonary Hospital &Thoracic Cancer Institute, School of Medicine, Tongji University, Shanghai, 200092, China.
Wen L; Department of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, 510510, China.
Pan Y; Department of Oncology, Shanghai Pulmonary Hospital &Thoracic Cancer Institute, School of Medicine, Tongji University, Shanghai, 200092, China.
Shan C; Department of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, 510510, China.
Hong W; Department of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, 510510, China.
Wang H; Department of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, 510510, China.
Zhou C; Department of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, 510510, China.
Cai L; Department of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, 510510, China. .
Zhou C; Department of Oncology, Shanghai Pulmonary Hospital &Thoracic Cancer Institute, School of Medicine, Tongji University, Shanghai, 200092, China. dr_.; Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, School of Medicine, Tongji University, No. 507, Zheng Min Road, Shanghai, 200433, China. dr_.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 May 25; Vol. 22 (1), pp. 580. Date of Electronic Publication: 2022 May 25.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/complications
Adenocarcinoma of Lung*/pathology
Carcinoma, Non-Small-Cell Lung*/pathology
Cerebrospinal Fluid*/chemistry
Cerebrospinal Fluid*/metabolism
Lung Neoplasms*/pathology
Meningeal Carcinomatosis*/complications
Meningeal Carcinomatosis*/secondary
ErbB Receptors/cerebrospinal fluid ; ErbB Receptors/genetics ; High-Throughput Nucleotide Sequencing ; Humans ; Mutation ; Protein Kinase Inhibitors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.
Autorzy:
Xian H; Department of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University, Beijing, 100191, China.
Li Y; Department of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University, Beijing, 100191, China.
Zou B; Department of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University, Beijing, 100191, China.
Chen Y; Department of Rehabilitation Medicine, Kunming Medical University, 1168 Western Chunrong Road, Yuhua Street, Chenggong District, Kunming, 650500, Yunnan, China.
Yin H; Department of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University, Beijing, 100191, China.
Li X; Department of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University, Beijing, 100191, China.
Pan Y; Department of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University, Beijing, 100191, China. .; Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing, 100191, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Jan 25; Vol. 22 (1), pp. 107. Date of Electronic Publication: 2022 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung/*genetics
Cell Cycle Proteins/*genetics
Circadian Clocks/*genetics
Intracellular Signaling Peptides and Proteins/*genetics
Lung Neoplasms/*genetics
Nuclear Receptor Subfamily 1, Group F, Member 1/*genetics
Biomarkers, Tumor/genetics ; Carcinoma, Non-Small-Cell Lung/mortality ; Circadian Rhythm/genetics ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Kaplan-Meier Estimate ; Lung Neoplasms/mortality ; Mutation ; Prognosis ; Proportional Hazards Models
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.
Autorzy:
Jiang T; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, No.507, Zhengmin Road, Shanghai, 200433, China.
Chen J; Hunan Cancer Hospital, Changsha, China.
Xu X; Northern Jiangsu People's Hospital, Yangzhou, China.
Cheng Y; Jilin Cancer Hospital, Changchun, China.
Chen G; Harbin Medical University Cancer Hospital, Harbin, China.
Pan Y; Anhui Provincial Hospital, Hefei, China.
Fang Y; Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, China.
Wang Q; Henan Cancer Hospital, Zhengzhou, China.
Huang Y; Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Centre, Kunming, China.
Yao W; Sichuan Provincial Cancer Hospital, Chengdu, China.
Wang R; Anhui Chest Hospital, Hefei, China.
Li X; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhang W; The First Affiliated Hospital of Nanchang University, Nanchang, China.
Zhang Y; Shaanxi Provincial Cancer Hospital, Xi'an, China.
Hu S; Hubei Cancer Hospital, Wuhan, China.
Guo R; Jiangsu Province Hospital, Nanjing, China.
Shi J; LinYi Cancer Hospital, Linyi, China.
Wang Z; Tangshan People's Hospital, Tangshan, China.
Cao P; The Third Xiangya Hospital of Central South University, Changsha, China.
Wang D; Chongqing University Cancer Hospital, Chongqing, China.
Fang J; Beijing Cancer Hospital, Beijing, China.
Luo H; Jiangxi Cancer Hospital, Nanchang, China.
Geng Y; Baoji Central Hospital, Baoji, China.
Xing C; Jinan Central Hospital, Jinan, China.
Lv D; Taizhou Hospital of Zhejiang Province, Taizhou, China.
Zhang Y; Zhejiang Cancer Hospital, Hangzhou, China.
Yu J; Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Cang S; Henan Provincial People's Hospital, Zhengzhou, China.
Zhang Y; Genecast Biotechnology Co., Ltd., Wuxi City, China.
Zhang J; Genecast Biotechnology Co., Ltd., Wuxi City, China.
Yang Z; Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Shi W; Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Zou J; Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Zhou C; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, No.507, Zhengmin Road, Shanghai, 200433, China. caicunzhou_.
Ren S; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, No.507, Zhengmin Road, Shanghai, 200433, China. harry_.
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2022 Jan 03; Vol. 21 (1), pp. 4. Date of Electronic Publication: 2022 Jan 03.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*
Cell-Free Nucleic Acids*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Squamous Cell/*blood
Carcinoma, Squamous Cell/*drug therapy
Lung Neoplasms/*blood
Lung Neoplasms/*drug therapy
Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carcinoma, Squamous Cell/diagnosis ; Carcinoma, Squamous Cell/etiology ; Combined Modality Therapy ; Computational Biology/methods ; DNA, Neoplasm ; Female ; Humans ; Lung Neoplasms/diagnosis ; Lung Neoplasms/etiology ; Male ; Middle Aged ; Molecular Targeted Therapy/methods ; Mutation ; Neoplasm Staging ; Prognosis ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of transcriptional subtypes in lung adenocarcinoma and squamous cell carcinoma through integrative analysis of microarray and RNA sequencing data.
Autorzy:
Fauteux F; Digital Technologies Research Centre, National Research Council Canada, Ottawa, ON, Canada. .
Surendra A; Digital Technologies Research Centre, National Research Council Canada, Ottawa, ON, Canada.
McComb S; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.
Pan Y; Digital Technologies Research Centre, National Research Council Canada, Ottawa, ON, Canada.
Hill JJ; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Apr 22; Vol. 11 (1), pp. 8709. Date of Electronic Publication: 2021 Apr 22.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Oligonucleotide Array Sequence Analysis*
Transcription, Genetic*
Adenocarcinoma/*genetics
Carcinoma, Squamous Cell/*genetics
Lung Neoplasms/*genetics
Sequence Analysis, RNA/*methods
Biomarkers, Tumor/genetics ; Gene Expression Profiling ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Amplified LncRNA PVT1 promotes lung cancer proliferation and metastasis by facilitating VEGFC expression.
Autorzy:
Pan Y; Key Laboratory of Heilongjiang Province for Cancer Prevention and Control, School of Basic Medicine, Mudanjiang Medical University, Mudanjiang 157011, Heilongjiang, P.R. China.
Liu L; Key Laboratory of Heilongjiang Province for Cancer Prevention and Control, School of Basic Medicine, Mudanjiang Medical University, Mudanjiang 157011, Heilongjiang, P.R. China.
Cheng Y; Key Laboratory of Heilongjiang Province for Cancer Prevention and Control, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang 157011, Heilongjiang, P.R. China.
Yu J; Key Laboratory of Heilongjiang Province for Cancer Prevention and Control, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang 157011, Heilongjiang, P.R. China.
Feng Y; Key Laboratory of Heilongjiang Province for Cancer Prevention and Control, School of Basic Medicine, Mudanjiang Medical University, Mudanjiang 157011, Heilongjiang, P.R. China.
Pokaż więcej
Źródło:
Biochemistry and cell biology = Biochimie et biologie cellulaire [Biochem Cell Biol] 2020 Dec; Vol. 98 (6), pp. 676-682. Date of Electronic Publication: 2020 Nov 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell Proliferation*
Gene Expression Regulation, Neoplastic*
Lung Neoplasms/*metabolism
Neoplasm Proteins/*biosynthesis
RNA, Long Noncoding/*metabolism
RNA, Neoplasm/*metabolism
Vascular Endothelial Growth Factor C/*biosynthesis
A549 Cells ; Animals ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Neoplasm Metastasis ; Neoplasm Proteins/genetics ; RNA, Long Noncoding/genetics ; RNA, Neoplasm/genetics ; Vascular Endothelial Growth Factor C/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung Cancer.
Autorzy:
Duan J; Department of Oncology, Huzhou Hospital of Traditional Chinese Medicine, No. 315 South Street, Huzhou, Zhejiang Province, China 313000.
Pan Y; Department of Oncology, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, Zhejiang Province, China 313000.
Yang X; Department of Oncology, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, Zhejiang Province, China 313000.
Zhong L; Department of Oncology, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, Zhejiang Province, China 313000.
Jin Y; Department of Laboratory Medicine, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, Zhejiang Province, China 313000.
Xu J; Graduate School of Nursing, Huzhou University, Huzhou, Zhejiang, No. 1 Bachelor Road, Huzhou, Zhejiang Province, China 313000.
Zhuang J; Graduate School of Nursing, Huzhou University, Huzhou, Zhejiang, No. 1 Bachelor Road, Huzhou, Zhejiang Province, China 313000.
Han S; Department of Oncology, Huzhou Central Hospital, Affiliated Central Hospital Huzhou University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, Zhejiang Province, China 313000.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2020 Nov 14; Vol. 2020, pp. 5816763. Date of Electronic Publication: 2020 Nov 14 (Print Publication: 2020).
Typ publikacji:
Journal Article
MeSH Terms:
Gene Regulatory Networks*
Carcinoma, Non-Small-Cell Lung/*genetics
Carcinoma, Non-Small-Cell Lung/*immunology
Lung Neoplasms/*genetics
Lung Neoplasms/*immunology
MicroRNAs/*genetics
RNA, Long Noncoding/*genetics
T-Lymphocytes/*immunology
Adenocarcinoma of Lung/genetics ; Adenocarcinoma of Lung/immunology ; CD8-Positive T-Lymphocytes/immunology ; Gene Expression Profiling ; Gene Expression Regulation ; Gene Expression Regulation, Neoplastic ; Gene Ontology ; Humans ; Immunologic Memory ; Kaplan-Meier Estimate ; Lymphocyte Activation/immunology ; MicroRNAs/metabolism ; Prognosis ; Protein Interaction Maps/genetics ; RNA, Long Noncoding/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
miR‑192‑5p upregulation mediates the suppression of curcumin in human NSCLC cell proliferation, migration and invasion by targeting c‑Myc and inactivating the Wnt/β‑catenin signaling pathway.
Autorzy:
Pan Y; Department of Pharmacy, The Tengzhou Central People's Hospital, Tengzhou, Shandong 277500, P.R. China.
Sun Y; Department of Pharmacy, Yantai Hospital of Traditional Chinese Medicine, Yantai, Shandong 264000, P.R. China.
Liu Z; Department of Pharmacy, Yantai Hospital of Traditional Chinese Medicine, Yantai, Shandong 264000, P.R. China.
Zhang C; Department of Pharmacy, The Tengzhou Central People's Hospital, Tengzhou, Shandong 277500, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2020 Aug; Vol. 22 (2), pp. 1594-1604. Date of Electronic Publication: 2020 Jun 04.
Typ publikacji:
Journal Article
MeSH Terms:
Genes, myc*
Carcinoma, Non-Small-Cell Lung/*metabolism
Curcumin/*pharmacology
Lung Neoplasms/*metabolism
MicroRNAs/*physiology
Wnt Signaling Pathway/*drug effects
A549 Cells ; Antineoplastic Agents/pharmacology ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; HEK293 Cells ; Humans ; Lung Neoplasms/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma.
Autorzy:
Pan Y; Department of Respiratory Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Huinan Town, Pudong, Shanghai 201399; Department of Bioinformatics, School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing, China.
Sha Y; Department of Bioinformatics, First Clinical Medical College of Nanjing Medical University, Nanjing, China.
Wang H; Department of Bioinformatics, First Clinical Medical College of Nanjing Medical University, Nanjing, China.
Zhuang H; Department of Bioinformatics, First Clinical Medical College of Nanjing Medical University, Nanjing, China.
Ren X; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhu X; Department of Respiratory Medicine, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Huinan Town, Pudong, Shanghai 201399, China.
Wei X; Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2020; Vol. 16 (2), pp. 320-326.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Adenocarcinoma of Lung/*immunology
Biomarkers, Tumor/*genetics
Computational Biology/*methods
Lung Neoplasms/*immunology
Lymphocytes, Tumor-Infiltrating/*immunology
Tumor Escape/*immunology
Adenocarcinoma of Lung/genetics ; Adenocarcinoma of Lung/pathology ; Aged ; Algorithms ; Biomarkers, Tumor/immunology ; Case-Control Studies ; Cohort Studies ; Databases, Genetic ; Female ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Male ; Middle Aged ; Prognosis ; Risk Factors ; Tumor Escape/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Low-density lipoprotein cholesterol levels are positively associated with the risk of endobronchial biopsy-induced refractory hemorrhage in patients with lung cancer.
Autorzy:
Wang S; Department of Respiratory Medicine, Jinhua Municipal Central Hospital, Jinhua Hospital of Zhejiang University, No. 365, East Renmin Road, Jinhua, 321000, Zhejiang Province, China. .
Hu X; Department of Cardiovascular Medicine, Jinhua Municipal Central Hospital, Jinhua Hospital of Zhejiang University, No. 365, East Renmin Road, Jinhua, 321000, Zhejiang Province, China.
Pan Y; Department of Cardiovascular Medicine, Jinhua Municipal Central Hospital, Jinhua Hospital of Zhejiang University, No. 365, East Renmin Road, Jinhua, 321000, Zhejiang Province, China. .
Pokaż więcej
Źródło:
Lipids in health and disease [Lipids Health Dis] 2019 Nov 04; Vol. 18 (1), pp. 190. Date of Electronic Publication: 2019 Nov 04.
Typ publikacji:
Journal Article
MeSH Terms:
Biopsy/*adverse effects
Cholesterol, LDL/*blood
Hemorrhage/*blood
Lung Neoplasms/*blood
Aged ; Bronchoscopy ; Female ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Odds Ratio ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Overexpression of ANLN in lung adenocarcinoma is associated with metastasis.
Autorzy:
Xu J; Department of Senior Ward, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Zheng H; National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Yuan S; Department of Pancreatic Cancer, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Zhou B; Department of Pancreatic Cancer, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Zhao W; Department of Breast Cancer, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Pan Y; Department of Senior Ward, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Qi D; Department of Senior Ward, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2019 Aug; Vol. 10 (8), pp. 1702-1709. Date of Electronic Publication: 2019 Jul 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma of Lung/*metabolism
Lung Neoplasms/*metabolism
Microfilament Proteins/*biosynthesis
A549 Cells ; Adenocarcinoma of Lung/genetics ; Adenocarcinoma of Lung/pathology ; Cell Line, Tumor ; Female ; Humans ; Immunohistochemistry ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Male ; Microfilament Proteins/genetics ; Microfilament Proteins/metabolism ; Middle Aged ; Neoplasm Metastasis ; Transfection
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of pulmonary nodules via CT images with hierarchical fully convolutional networks.
Autorzy:
Chen G; Ningbo Institute of Technology, Zhejiang University, Ningbo, 315100, China. .; Ningbo Research Institute, Zhejiang University, Ningbo, 315100, China. .
Zhang J; College of Computer Science, Zhejiang University, Hangzhou, 315100, China.
Zhuo D; College of Computer Science, Zhejiang University, Hangzhou, 315100, China.
Pan Y; Department of Radiology, Ningbo First Hospital, Ningbo Hospital, Zhejiang University, Ningbo, 315100, China.
Pang C; Ningbo Institute of Technology, Zhejiang University, Ningbo, 315100, China.
Pokaż więcej
Źródło:
Medical & biological engineering & computing [Med Biol Eng Comput] 2019 Jul; Vol. 57 (7), pp. 1567-1580. Date of Electronic Publication: 2019 Apr 25.
Typ publikacji:
Journal Article
MeSH Terms:
Imaging, Three-Dimensional/*methods
Lung Neoplasms/*diagnostic imaging
Tomography, X-Ray Computed/*methods
Algorithms ; Databases, Factual ; Humans ; Lung Neoplasms/pathology ; Sensitivity and Specificity ; Solitary Pulmonary Nodule/diagnostic imaging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma.
Autorzy:
Xu M; Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu, China.; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, 215006, Jiangsu, China.
Wang X; The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215006, Jiangsu, China.
Pan Y; Drug Farm. Inc, Shanghai, 200000, China.
Zhao X; Clinical Laboratory Center, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, 471000, Henan, China.
Yan B; Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu, China.; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, 215006, Jiangsu, China.
Ruan C; Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu, China.; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, 215006, Jiangsu, China.
Xia L; Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu, China.; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, 215006, Jiangsu, China.; State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123, China.
Zhao Y; Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of the Ministry of Health, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, Jiangsu, China. .; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, 215006, Jiangsu, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2019 Jun 17; Vol. 19 (1), pp. 599. Date of Electronic Publication: 2019 Jun 17.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents, Immunological/*pharmacology
Lectins, C-Type/*metabolism
Lung Neoplasms/*metabolism
Melanoma/*metabolism
Membrane Glycoproteins/*antagonists & inhibitors
Membrane Glycoproteins/*metabolism
Nasopharyngeal Neoplasms/*metabolism
Animals ; CHO Cells ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cricetulus ; Female ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Neoplasm Metastasis ; Platelet Aggregation/drug effects ; Signal Transduction/drug effects ; Tumor Burden ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 48

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies